- Home
- NVGS vs SPRY Comparison
NVGS vs SPRY Comparison
Compare NVGS & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- SPRY
- Stock Information
- Founded
- NVGS 1997
- SPRY 2015
- Country
- NVGS United Kingdom
- SPRY United States
- Employees
- NVGS N/A
- SPRY N/A
- Industry
- NVGS Marine Transportation
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- NVGS Consumer Discretionary
- SPRY Health Care
- Exchange
- NVGS Nasdaq
- SPRY Nasdaq
- Market Cap
- NVGS 994.3M
- SPRY 1.6B
- IPO Year
- NVGS N/A
- SPRY N/A
- Fundamental
- Price
- NVGS $15.23
- SPRY $16.95
- Analyst Decision
- NVGS Strong Buy
- SPRY Strong Buy
- Analyst Count
- NVGS 3
- SPRY 4
- Target Price
- NVGS $22.00
- SPRY $28.75
- AVG Volume (30 Days)
- NVGS 709.3K
- SPRY 1.5M
- Earning Date
- NVGS 08-13-2025
- SPRY 08-05-2025
- Dividend Yield
- NVGS 1.31%
- SPRY N/A
- EPS Growth
- NVGS 9.28
- SPRY N/A
- EPS
- NVGS 1.27
- SPRY N/A
- Revenue
- NVGS $583,931,000.00
- SPRY $97,122,000.00
- Revenue This Year
- NVGS $3.45
- SPRY N/A
- Revenue Next Year
- NVGS N/A
- SPRY $140.40
- P/E Ratio
- NVGS $11.95
- SPRY N/A
- Revenue Growth
- NVGS 6.38
- SPRY 971120.00
- 52 Week Low
- NVGS $10.55
- SPRY $8.77
- 52 Week High
- NVGS $18.18
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- NVGS 65.17
- SPRY 55.33
- Support Level
- NVGS $13.90
- SPRY $15.75
- Resistance Level
- NVGS $14.90
- SPRY $18.90
- Average True Range (ATR)
- NVGS 0.42
- SPRY 1.04
- MACD
- NVGS 0.02
- SPRY 0.01
- Stochastic Oscillator
- NVGS 88.50
- SPRY 49.26
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.